Search clinical trials for: 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
Total 45 results
-
Peking Union Medical College HospitalRecruitingDiagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617Renal Cell CarcinomaChina
-
Peking Union Medical College HospitalRecruitingAdenoid Cystic CarcinomaChina
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)UnknownMetastatic Castration-resistant Prostate CancerChina
-
Peter MacCallum Cancer Centre, AustraliaEndocyte; Movember Foundation; Medical Research Future Fund; E.J. Whitten Foundation...Active, not recruitingProstatic NeoplasmsAustralia
-
Peking Union Medical College HospitalRecruiting
-
Centre Georges Francois LeclercNot yet recruitingPatients With Metastatic Castration-resistant Prostate Cancer
-
Novartis PharmaceuticalsRecruitingProstate CancerUnited States
-
Peking Union Medical College HospitalCompletedMetastatic Castration-resistant Prostate CancerChina
-
University of California, San FranciscoMerck Sharp & Dohme LLC; Prostate Cancer FoundationRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate CancerUnited States
-
Vadim S KoshkinEli Lilly and Company; Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Castration-resistant Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Castration-resistant Prostate CarcinomaUnited States
-
Peking Union Medical College HospitalRecruitingNeuroendocrine TumorsChina
-
Peter MacCallum Cancer Centre, AustraliaUnited States Department of Defense; Advanced Accelerator Applications; Australian... and other collaboratorsActive, not recruitingMetastatic Hormone Naive Prostate CancerAustralia
-
Advanced Accelerator ApplicationsNo longer availableMetastatic Castration-resistant Prostate Cancer (mCRPC)
-
Weill Medical College of Cornell UniversityTerminated
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers Squibb; University of Sydney; Advanced Accelerator Applications; Prostate...Active, not recruitingNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Prostate Cancer | Prostatic DiseaseAustralia
-
Radboud University Medical CenterCompleted
-
University of UtahExelixisRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
The Netherlands Cancer InstituteUMC Utrecht; Advanced Accelerator ApplicationsRecruiting
-
Weill Medical College of Cornell UniversityActive, not recruitingProstate CancerUnited States
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
University of California, San FranciscoNational Cancer Institute (NCI); Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Castration Levels of Testosterone | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
Novartis PharmaceuticalsAlliance Foundation Trials, LLC.; RTOG Foundation, Inc.Active, not recruitingProstatic NeoplasmsUnited States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Novartis PharmaceuticalsRecruitingProstatic NeoplasmKorea, Republic of, Singapore, United States, Canada, Poland, Spain, Czechia
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsActive, not recruitingProstate CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingProstatic NeoplasmsBelgium, Canada, Spain, Germany, Austria, Netherlands, United Kingdom, United States, France, Switzerland, Sweden, Slovakia, Poland, Czechia
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
EndocyteCompletedProstate CancerUnited States, United Kingdom, Canada, Netherlands, Sweden, France, Puerto Rico, Belgium, Denmark, Germany
-
Radboud University Medical CenterAdvanced Accelerator Applications; ProstaatkankerstichtingRecruitingProstate CancerNetherlands, Cyprus
-
EndocyteTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHActive, not recruitingProstate CancerJapan
-
Australian and New Zealand Urogenital and Prostate...Endocyte; Movember Foundation; Australian Nuclear Science and Technology Organisation... and other collaboratorsCompletedMetastatic Cancer | Cancer of the ProstateAustralia
-
Canadian Cancer Trials GroupEndocyte; Prostate Cancer CanadaActive, not recruiting
-
Jonsson Comprehensive Cancer CenterNot yet recruitingProstate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Mayo ClinicNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
University of WashingtonNovartis; Institute for Prostate Cancer Research (IPCR)Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteNovartisNot yet recruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsNot yet recruitingMetastatic Neuroendocrine Prostate Cancer
-
Rohan GarjeJanssen Scientific Affairs, LLCNot yet recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
Kronos Longevity Research InstituteMayo Clinic; Albert Einstein College of Medicine; Yale University; Columbia University and other collaboratorsUnknown